Molecular biosensors: promising new tools for early detection of cancer

References

• Weinberg R. The Biology of Cancer. New York, NY, USA: Garland Science; 2013.
   Google Scholar
• Imielinski M, Berger AH, Hammerman PS, et al. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell. 2012;150:1107–1120.
   PubMed Web of Science ®Google Scholar
• Chung CC, Ciampa J, Yeager M, et al. Fine mapping of a region of chromosome 11q13 reveals multiple independent loci associated with risk of prostate cancer. Hum Mol Genet. 2011;20:2869–2878.
   Web of Science ®Google Scholar
• Tang W, Fu YP, Figueroa JD, et al. Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer. Hum Mol Genet. 2012;21:1918–1930.
   PubMed Web of Science ®Google Scholar
• Altintas Z, Uludag Y, Gurbuz Y, Tothill IE. Surface plasmon resonance based immunosensor for the detection of the cancer biomarker carcinoembryonic antigen. Talanta. 2011;86:377–383.
   PubMed Web of Science ®Google Scholar
• Woolner LB, McDonald JR. Biopsy in cancer diagnosis. Plast Reconstr Surg. 1952;9:388.
   Google Scholar
• Kronz JD, Allan CH, Shaikh AA, Epstein JI. Predicting cancer following a diagnosis of high-grade prostatic intraepithelial neoplasia on needle biopsy: data on men with more than one follow-up biopsy. Am J Surg Pathol. 2001;25:1079–1095.
   PubMed Web of Science ®Google Scholar
• Mao L, Hruban RH, Boyle JO, Tockman M, Sidransky D. Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res. 1994;54:1634–1637.
   PubMed Web of Science ®Google Scholar
• Palmisano WA, Divine KK, Saccomanno G, et al. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res. 2000;60:5954–5958.
   PubMed Web of Science ®Google Scholar
• Boice JD Jr, Preston D, Davis FG, Monson RR. Frequent chest X-ray fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts. Radiat Res. 1991;125:214–222.
   PubMed Web of Science ®Google Scholar
• de GonzÁlez AB, Darby S. Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries. Lancet. 2004;363:345–351.
   PubMed Web of Science ®Google Scholar
• Leach MO, Boggis CR, Dixon AK, et al; MARIBS Study Group. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet. 2005;365:1769–1778.
   PubMed Web of Science ®Google Scholar
• Beets-Tan RG, Beets GL, Vliegen RF, et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet. 2001;357:497–504.
   PubMed Web of Science ®Google Scholar
• Watt I, Stewart I, Anderson D, Bell G, Anderson JR. Laparoscopy, ultrasound and computed tomography in cancer of the oesophagus and gastric cardia: a prospective comparison for detecting intra-abdominal metastases. Br J Surg. 1989;76:1036–1039.
   PubMed Web of Science ®Google Scholar
• Lardinois D, Weder W, Hany TF, et al. Staging of non–small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med. 2003;348:2500–2507.
   PubMed Web of Science ®Google Scholar
• Ollinger JM, Fessler JA. Positron-emission tomography. IEEE Signal Process Mag. 1997;14:43–55.
   Web of Science ®Google Scholar
• Ter-Pogossian MM, Raichle ME, Sobel BE. Positron-emission tomography. Sci Am. 1980;243:170–181.
   Web of Science ®Google Scholar
• Jain KK. Nanodiagnostics: application of nanotechnology in molecular diagnostics. Expert Rev Mol Diagn. 2003;3:153–161.
   PubMed Web of Science ®Google Scholar
• Chikkaveeraiah BV, Mani V, Patel V, Gutkind JS, Rusling JF. Microfluidic electrochemical immunoarray for ultrasensitive detection of two cancer biomarker proteins in serum. Biosens Bioelectron. 2011;26:4477–4483.
   PubMed Web of Science ®Google Scholar
• Dimov IK, Basabe-Desmonts L, Garcia-Cordero JL, et al. Stand-alone self-powered integrated microfluidic blood analysis system (SIMBAS). Lab Chip. 2011;11:845–850.
   PubMed Web of Science ®Google Scholar
• Malhotra R, Patel V, Chikkaveeraiah BV, et al. Ultrasensitive detection of cancer biomarkers in the clinic by use of a nanostructured microfluidic array. Anal Chem. 2012;84:6249–6255.
   PubMed Web of Science ®Google Scholar
• Altintas Z, Tothill I. Biomarkers and biosensors for the early diagnosis of lung cancer. Sens Actuators B Chem. 2013;188:988–998.
   Web of Science ®Google Scholar
• Altintas Z, Fakanya WM, Tothill IE. Cardiovascular disease detection using bio-sensing techniques. Talanta. 2014;128:177–186.
   Web of Science ®Google Scholar
• Fakanya WM, Altintas Z, Tothill IE. Biosensors for heart disease diagnosis, In: Biosensors and their application in healthcare. (e-book), Future Science Group, UK; 2013. 128–143.
   Google Scholar
• Tothill IE. Biosensors for cancer markers diagnosis. Semin Cell Dev Biol. 2009;20:55–62.
   PubMed Web of Science ®Google Scholar
• Altintas Z, Kallempudi SS, Gurbuz Y. Gold nanoparticle modified capacitive sensor platform for multiple marker detection. Talanta. 2014;118:270–276.
   Web of Science ®Google Scholar
• Altintas Z, Kallempudi SS, Sezerman U, Gurbuz Y. A novel magnetic particle-modified electrochemical sensor for immunosensor applications. Sens Actuators B Chem. 2012;174:187–194.
   Web of Science ®Google Scholar
• Isobe M, Emanuel BS, Givol D, Oren M, Croce CM. Localization of gene for human p53 tumour antigen to band 17p13. Nature. 1986;12:84–85.
   Google Scholar
• Sonoyama T, Sakai A, Mita Y, et al. TP53 codon 72 polymorphism is associated with pancreatic cancer risk in males, smokers and drinkers. Mol Med Rep. 2011;4:489–495.
   PubMed Web of Science ®Google Scholar
• Alawadi S, Ghabreau L, Alsaleh M, et al. P53 gene polymorphisms and breast cancer risk in Arab women. Med Oncol. 2011;28:709–715.
   Google Scholar
• Hainaut P, Pfeifer GP. Patterns of p53 G? T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke. Carcinogenesis. 2001;22:367–374.
   PubMed Web of Science ®Google Scholar
• Ciardiello F, Tortora G. EGFR antagonists in cancer treatment. N Engl J Med. 2008;358:1160–1174.
   PubMed Web of Science ®Google Scholar
• Bouchal P, Dvorakova M, Scherl A, Garbis SD, Nenutil R, Vojtesek B. Intact protein profiling in breast cancer biomarker discovery: protein identification issue and the solutions based on 3D protein separation, bottom-up and top-down mass spectrometry. Proteomics. 2013;13:1053–1058.
   Web of Science ®Google Scholar
• Wheelock CE, Goss VM, Balgoma D, et al. Application of’omics technologies to biomarker discovery in inflammatory lung diseases. Eur Respir J. 2013;42:802–825.
   PubMed Web of Science ®Google Scholar
• Mayr M, Zampetaki A, Willeit P, Willeit J, Kiechl S. MicroRNAs within the continuum of postgenomics biomarker discovery. Arterioscler Thromb Vasc Biol. 2013;33:206–214.
   PubMed Web of Science ®Google Scholar
• Hanash SM, Bobek MP, Rickman DS, et al. Integrating cancer genomics and proteomics in the post-genome era. Proteomics. 2002;2:69–75.
   PubMed Web of Science ®Google Scholar
• Imielinski M, Cha S, Rejtar T, Richardson EA, Karger BL, Sgroi DC. Integrated proteomic, transcriptomic, and biological network analysis of breast carcinoma reveals molecular features of tumorigenesis and clinical relapse. Mol Cell Proteomics. 2012;11:1–7.
   Web of Science ®Google Scholar
• Peng J, Ritchie JC, Van Meir EG. Proteomics of gliomas: initial biomarker discovery and evolution of technology. Neuro-oncology. 2011;13:926–942.
   Web of Science ®Google Scholar
• Casado-Vela J, CebriÁn A, Gómez del Pulgar MT, Lacal JC. Approaches for the study of cancer: towards the integration of genomics, proteomics and metabolomics. Clin Transl Oncol. 2011;13:617–628.
   PubMed Web of Science ®Google Scholar
• Chen G, Gharib TG, Huang CC, et al. Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics. 2002;1:304–313.
   PubMed Web of Science ®Google Scholar
• Kanehisa M, Bork P. Bioinformatics in the post-sequence era. Nat Genet. 2003;33:305–310.
   PubMed Web of Science ®Google Scholar
• Ørntoft TF, Thykjaer T, Waldman FM, Wolf H, Celis JE. Genome-wide study of gene copy numbers, transcripts, and protein levels in pairs of non-invasive and invasive human transitional cell carcinomas. Mol Cell Proteomics. 2002;1:37–45.
   PubMed Web of Science ®Google Scholar
• Lueking A, Huber O, Wirths C, et al. Profiling of alopecia areata autoantigens based on protein microarray technology. Mol Cell Proteomics. 2005;4:1382–1390.
   PubMed Web of Science ®Google Scholar
• Pauly F, Smedby KE, Jerkeman M, et al. Identification of B-cell lymphoma subsets by plasma protein profiling using recombinant antibody microarrays. Leuk Res. 2014;38:682–690.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Chan DW. The road from discovery to clinical diagnostics: lessons learned from the first FDA-cleared in vitro diagnostic multivariate index assay of proteomic biomarkers. Cancer Epidemiol Biomarkers Prev. 2010;19:2995–2999.
   PubMed Web of Science ®Google Scholar
• Frangogiannis NG. Biomarkers: hopes and challenges in the path from discovery to clinical practice. Transl Res. 2012;159:197–204.
   Web of Science ®Google Scholar
• Cantor CR. Orchestrating the Human Genome Project. Science. 1990;248(4951):49–51.
   Web of Science ®Google Scholar
• Uludag Y, Tothill IE. Cancer biomarker detection in serum samples using surface plasmon resonance and quartz crystal microbalance sensors with nanoparticle signal amplification. Anal Chem. 2012;84:5898–5904.
   PubMed Web of Science ®Google Scholar
• Altintas Z, Tothill IE. DNA-based biosensor platforms for the detection of TP53 mutation. Sens Actuators B Chem. 2012;169:188–194.
   Web of Science ®Google Scholar
• Wang Y, Zhu X, Wu M, Xia N, Wang J, Zhou F. Simultaneous and label-free determination of wild-type and mutant p53 at a single surface plasmon resonance chip preimmobilized with consensus DNA and monoclonal antibody. Anal Chem. 2009;81:8441–8446.
   Web of Science ®Google Scholar
• Ladd J, Lu H, Taylor AD, Goodell V, Disis ML, Jiang S. Direct detection of carcinoembryonic antigen autoantibodies in clinical human serum samples using a surface plasmon resonance sensor. Colloids Surf B Biointerfaces. 2009;70:1–6.
   PubMed Web of Science ®Google Scholar
• Lin YY, Wang J, Liu G, Wu H, Wai CM, Lin Y. A nanoparticle label/immunochromatographic electrochemical biosensor for rapid and sensitive detection of prostate-specific antigen. Biosens Bioelectron. 2008;23:1659–1665.
   PubMed Web of Science ®Google Scholar
• Ilyas A, Asghar W, Allen PB, Duhon H, Ellington AD, Iqbal SM. Electrical detection of cancer biomarker using aptamers with nanogap break-junctions. Nanotechnology. 2012;23:1–8.
   Web of Science ®Google Scholar
• Kallempudi SS, Altintas Z, Niazi JH, Gurbuz Y. A new microfluidics system with a hand-operated, on-chip actuator for immunosensor applications. Sens Actuators B Chem. 2012;163:194–201.
   Web of Science ®Google Scholar
• Sato Y, Fujimoto K, Kawaguchi H. Detection of a K-ras point mutation employing peptide nucleic acid at the surface of a SPR biosensor. Colloids Surf B Biointerfaces. 2003;27:23–31.
   Web of Science ®Google Scholar
• Ladd J, Taylor AD, Piliarik M, Homola J, Jiang S. Label-free detection of cancer biomarker candidates using surface plasmon resonance imaging. Anal Bioanal Chem. 2009;393:1157–1163.
   PubMed Web of Science ®Google Scholar
• Chung J, Bernhardt R, Pyun J. Additive assay of cancer marker CA 19-9 by SPR biosensor. Sens Actuators B Chem. 2006;118:28–32.
   Web of Science ®Google Scholar
• Miao X, Guo X, Xiao Z, Ling L. Electrochemical molecular beacon biosensor for sequence-specific recognition of double-stranded DNA. Biosens Bioelectron. 2014;59:54–57.
   PubMed Web of Science ®Google Scholar
• Xuan F, Luo X, Hsing I-M. Ultrasensitive solution-phase electrochemical molecular beacon-based DNA detection with signal amplification by exonuclease III-assisted target recycling. Anal Chem. 2012;84:5216–5220.
   PubMed Web of Science ®Google Scholar
• Lin Y-H, Tseng W-L. A room-temperature adenosine-based molecular beacon for highly sensitive detection of nucleic acids. Chem Commun (Camb). 2012;48:6262–6264.
   Web of Science ®Google Scholar
• Tang Z, Liu P, Ma C, et al. Molecular beacon based bioassay for highly sensitive and selective detection of nicotinamide adenine dinucleotide and the activity of alanine aminotransferase. Anal Chem. 2011;83:2505–2510.
   Web of Science ®Google Scholar
• Xu H, Hepel M. “Molecular beacon”-based fluorescent assay for selective detection of glutathione and cysteine. Anal Chem. 2011;83:813–819.
   Web of Science ®Google Scholar
• Piao Y, Liu F, Seo TS. A novel molecular beacon bearing a graphite nanoparticle as a nanoquencher for in situ mRNA detection in cancer cells. ACS Appl Mater Interfaces. 2012;4:6785–6789.
   Web of Science ®Google Scholar
• Yu Y, et al. in American Physical Society March Meeting Abstracts. 2013;1:1029–1030.
   Google Scholar
• Mathur A, Blais S, Goparaju CM, Neubert T, Pass H, Levon K. Development of a biosensor for detection of pleural mesothelioma cancer biomarker using surface imprinting. PLoS One. 2013;8:1–8.
   Web of Science ®Google Scholar
• Su L, Zou L, Fong CC, et al. Detection of cancer biomarkers by piezoelectric biosensor using PZT ceramic resonator as the transducer. Biosens Bioelectron. 2013;46:155–161.
   PubMed Web of Science ®Google Scholar
• Jain KK. Applications of nanobiotechnology in clinical diagnostics. Clin Chem. 2007;53:2002–2009.
   PubMed Web of Science ®Google Scholar
• Choi JS, Jun YW, Yeon SI, Kim HC, Shin JS, Cheon J. Biocompatible heterostructured nanoparticles for multimodal biological detection. J Am Chem Soc. 2006;128:15982–15983.
   PubMed Web of Science ®Google Scholar
• Xing Y, Chaudry Q, Shen C, et al. Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry. Nat Protoc. 2007;2:1152–1165.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang T-H. Quantum dot enabled molecular sensing and diagnostics. Theranostics. 2012;2:631–654.
   PubMed Web of Science ®Google Scholar
• El-Sayed IH, Huang X, El-Sayed MA. Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer. Nano Lett. 2005;5:829–834.
   PubMed Web of Science ®Google Scholar
• Na HB, Lee JH, An K, et al. Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles. Angew Chem Int Ed Engl. 2007;119:5493–5401.
   Google Scholar
• Ho YP, Kung MC, Yang S, Wang TH. Multiplexed hybridization detection with multicolor colocalization of quantum dot nanoprobes. Nano Lett. 2005;5:1693–1697.
   Web of Science ®Google Scholar
• Shanmukh S, Jones L, Driskell J, Zhao Y, Dluhy R, Tripp RA. Rapid and sensitive detection of respiratory virus molecular signatures using a silver nanorod array SERS substrate. Nano Lett. 2006;6(11):2630–2636.
   PubMed Web of Science ®Google Scholar
• Corsi F, De Palma C, Colombo M, et al. Towards ideal magnetofluorescent nanoparticles for bimodal detection of breast-cancer cells. Small. 2009;5:2555–2564.
   Web of Science ®Google Scholar
• Altintas Z, Uludag Y, Gurbuz Y, Tothill I. Development of surface chemistry for surface plasmon resonance based sensors for the detection of proteins and DNA molecules. Anal Chim Acta. 2012;712:138–144.
   Web of Science ®Google Scholar
• Medley CD, Smith JE, Tang Z, Wu Y, Bamrungsap S, Tan W. Gold nanoparticle-based colorimetric assay for the direct detection of cancerous cells. Anal Chem. 2008;80:1067–1072.
   PubMed Web of Science ®Google Scholar
• Smith JE, Medley CD, Tang Z, Shangguan D, Lofton C, Tan W. Aptamer-conjugated nanoparticles for the collection and detection of multiple cancer cells. Anal Chem. 2007;79:3075–3082.
   PubMed Web of Science ®Google Scholar
• Farias PM, Santos BS, Fontes A. Semiconductor fluorescent quantum dots: efficient biolabels in cancer diagnostics. Methods Mol Biol. 2009;544:407–419.
   Google Scholar